Foundation Medicine (Foundation Medicine) EV-to-EBIT : -36.75 (As of Apr. 26, 2024)

Foundation Medicine EV-to-EBIT Chart

Foundation Medicine Quarterly Data
	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18
EV-to-EBIT	Get a 7-Day Free Trial															-8.58	-8.67	-15.41	-19.47	-37.05

Competitive Comparison of Foundation Medicine's EV-to-EBIT

For the Diagnostics & Research subindustry, Foundation Medicine's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Foundation Medicine's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Foundation Medicine's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Foundation Medicine's EV-to-EBIT falls into.

Foundation Medicine EV-to-EBIT Calculation

Foundation Medicine's EV-to-EBIT for today is calculated as:

Foundation Medicine's current Enterprise Value is $5,087.8 Mil.
Foundation Medicine's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-138.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foundation Medicine  (NAS:FMI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Foundation Medicine's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2018 is calculated as:

Foundation Medicine's Enterprise Value for the quarter that ended in Jun. 2018 was $5,134.6 Mil.
Foundation Medicine's EBIT for the trailing twelve months (TTM) ended in Jun. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-138.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Foundation Medicine EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Foundation Medicine's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Foundation Medicine (Foundation Medicine) Business Description